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Abstract
A novel non-culture based 16S rRNA Terminal Restriction Fragment Length Polymorphism (T-RFLP) method using the
restriction enzymes Tsp509I and Hpy166II was developed for the characterization of the nasopharyngeal microbiota and
validated using recently published 454 pyrosequencing data. 16S rRNA gene T-RFLP for 153 clinical nasopharyngeal samples
from infants with acute otitis media (AOM) revealed 5 Tsp509I and 6 Hpy166II terminal fragments (TFs) with a prevalence of
.10%. Cloning and sequencing identified all TFs with a prevalence .6% allowing a sufficient description of bacterial
community changes for the most important bacterial taxa. The conjugated 7-valent pneumococcal polysaccharide vaccine
(PCV-7) and prior antibiotic exposure had significant effects on the bacterial composition in an additive main effects and
multiplicative interaction model (AMMI) in concordance with the 16S rRNA 454 pyrosequencing data. In addition, the
presented T-RFLP method is able to discriminate S. pneumoniae from other members of the Mitis group of streptococci,
which therefore allows the identification of one of the most important human respiratory tract pathogens. This is usually
not achieved by current high throughput sequencing protocols. In conclusion, the presented 16S rRNA gene T-RFLP method
is a highly robust, easy to handle and a cheap alternative to the computationally demanding next-generation sequencing
analysis. In case a lot of nasopharyngeal samples have to be characterized, it is suggested to first perform 16S rRNA T-RFLP
and only use next generation sequencing if the T-RFLP nasopharyngeal patterns differ or show unknown TFs.
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Introduction
Previous studies on the nasopharyngeal microbiota have mainly
relied on conventional culture identification of the major
pathogens Streptococcus pneumoniae, Haemophilus influenzae, Stahphylo-
coccus aureus and Moraxella catarrhalis. These bacteria colonize the
human nasopharynx as a first step in the pathogenesis of acute
otitis media (AOM) [1,2,3,4]. However, selective analysis focusing
only on a few pathogens may lead to an underestimation of the
influence of a generally disturbed or altered nasopharyngeal
microbiota on disease progression.
In recent years there has been significant development of non-
cultural methods to characterize microbial communities of
different human body sites [5,6,7,8]. Among those, next-genera-
tion sequencing (e.g., 454 and Illumina pyrosequencing) seems to
be the most appropriate technique for the future. It is based on the
amplification of 16S rRNA gene which has been widely used as a
bacterial classification marker [9]. Using primers specific for
conserved border regions and subsequent analysis of the variable
sections amplified in-between allows species identification. How-
ever, there is no standardized protocol for analyzing high
throughput data and careful evaluation is needed. Among the
parameters, which could have an influence on the outcome of the
analysis are i) the choice of primers, ii) the DNA extraction
protocols, iii) the amplification conditions, iv) the alignment of
sequences and v) the Operational Taxonomic Unit (OTU)
definition.
In a recent study, we investigated the influence of antibiotic
consumption and vaccination with the conjugated 7-valent
pneumococcal polysaccharide vaccine (PCV-7) on the nasopha-
ryngeal microbiota in children with and without AOM using 454
16S rRNA sequencing [10]. Within this study, an alternative 16S
rRNA Terminal Restriction Fragment Length Polymorphism (T-
RFLP) method to characterize the microbiota of the nasopharynx
was developed and validated. This novel approach offers the
advantages of being quick, easy to handle and cheap.
Materials and Methods
Ethics statement. Samples used for this study were collected
within a nationwide surveillance program from outpatients with
acute otitis media, which is ongoing since 1998. This surveillance
program is part of the governmental public health surveillance and
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is therefore exempted from approval by Institutional Review
Boards.
In silico Design of Terminal Restriction Fragment Length
Polymorphism (T-RFLP)
We downloaded 38 16S rRNA sequences of bacteria reported to
be characteristic for the nasopharynx [10] which were then
trimmed in 4 different groups ranging from 8F-907, 8F-1391,
341–907 and 341–1391 (E. coli numbering). These groups were
uploaded to the restriction Enzyme Picker website (http://
rocaplab.ocean.washington.edu/tools/repk) to select enzymes
which showed the highest possible discriminatory power. This
website stores 16S rRNA sequences and shows a ranking and
combination of enzymes for optimal bacterial 16S diversity
coverage. Moreover, an emphasis was laid on the fact that the
enzymes could distinguish the ‘commensal’ Mitis group members
from Streptococcus pneumoniae. Based on these criteria, product sizes
ranging from 8F-907 using the restriction enzymes TSP509I and
Hpy166II were received.
For PCR reactions, only forward primer 8F was labeled with
Carboxyfluorescein (FAM) as in silico analysis revealed that
labeling of reverse primer 907 would not lead to additional
discrimination. In silico fragment lengths of common nasopharyn-
geal species using the above criteria were received using Mica
(http://mica.ibest.uidaho.edu/trflp.php), assuming that experi-
mental results will differ by about 1%.
DNA Extraction from Bacterial Cultures and PCR
Amplification
To receive the in vitro terminal fragment (TF) lengths (compared
to in silico as above) of common nasopharyngeal species,
chromosomal DNA was extracted from Streptococcus mitis, S.
pseudopneumoniae, S. pneumoniae, S. oralis, S. gordonii, S. pyogenes, S.
sanguinis, Pseudomonas aeruginosa, Rhodococcus equi, Corynebacterium
pseudodiphtheriticum, Staphylococcus epidermidis, S. aureus, Haemophilus
influenzae, Moraxella catarrhalis and Klebsiella pneumoniae as previously
described [11,12]. PCR reactions were performed in a total
volume of 50 ml using 16fast start Taq reaction buffer, 1.5 mM
MgCl2, 0.2 mM dNTPs, 1 mM of primer 8F FAM-AGA GTT
TGA TCC TGG CTC AG and 1 mM of primer 907R CCG TCA
ATT CMT TTG AGT TT, 0.2 ml of Fast start Taq Polymerase
(Roche, Rotkreuz, Switzerland) and 2 ml of extracted DNA (2 ng/
ml). PCR cycling conditions included a heat activation step at 95uC
for 6 min, 35 cycles of denaturation at 95uC (30 s), annealing at
59uC (30 s) and elongation at 71uC (2 min) and a final elongation
step at 71uC for 7 min. PCR products were purified using the
Promega Wizard (Promega, Madison, WI).
T-RFLP Digestion and Detection Limits
Purified PCR products were checked for correct amplification
size and purity using the Agilent 2100 bioanalyzer (Agilent
Technologies, Palo Alto, CA) with the DNA 7500 LabChip kit.
Table 1. Predicted and observed terminal restriction
fragments (TFs) in bp after separate digestion with TSP509I
and Hpy166I.
Sample species name TSP509I Hpy166I
In silico In vitro In silico In vitro
Streptococcus mitis 207 204 470 465
Streptococcus pseudopneumoniae 671 665 470 465
Streptococcus pneumoniae 671 664 206 202
Streptococcus gordonii 186 195 480 475
Streptococcus pyogenes 195 189 804 795
Streptococcus sanguinis 174 169 472 467
Pseudomonas aeruginosa 547 538 793 784
Rhodococcus equi 523 515 79 73
Corynebacterium pseudodiphtheriticum 524 516 415 410
Staphylococcus epidermidis 558 549 805 794
Staphylococcus aureus 558 549 472 465
Haemophilus influenzae 469 463 798 790
Moraxella catarrhalis 541 535 788 780
Klebsiella pneumoniae 549 540 796 784
TFs were received using the labeled 8F primer.
doi:10.1371/journal.pone.0052241.t001
Figure 1. Terminal fragment (TF) prevalence in nasopharyngeal swabs from 153 infants with acute otitis media. Shown are the TF
frequencies (in %) for the two different restriction enzymes (blue for Tsp509I and red for Hpy166II).
doi:10.1371/journal.pone.0052241.g001
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The enzymatic digestions were performed in a total volume of
20 ml using 40 ng of the amplified and purified PCR product, 1 ml
NEB Reaction Buffer (New England Biolabs, Ipswich, MA) 1 (for
digestion with Tsp509I) or 4 (Hpy166II) and 0.5 ml of the restriction
enzymes Tsp509I or Hpy166II. Digestion conditions were 3 h at
65uC for TSP509I and 3 h at 37uC with 20 min enzyme
inactivation at 65uC for Hpy166II, respectively. Digested products
were purified and capillary electrophoresis was performed on an
AB 3130 genetic analyzer (Applied Biosystems, Rotkreuz, Swit-
zerland) as previously described [12]. Detection limits were tested
for Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis
and Corynebacterium pseudodiphtheriticum by amplifying serial dilutions.
16S rRNA T-RFLP of Nasopharyngeal Swabs from Infants
with AOM
We processed nasopharyngeal swabs collected from children
younger than 2 years within an on-going nationwide surveillance
program during four winter seasons in Switzerland [13]. The
presence of S. pneumoniae was verified by culture and plyNCR-PCR
data generated in earlier studies [11,12,14]. PCR and 16S gene T-
RFLP digestions with Tsp509I or Hpy166II were performed as
described above. The resulting T-RFLP electropherograms were
uploaded to the Peak Scanner Software v1.0 (Applied Biosystems,
Carlsbad, CA). Background noise was eliminated by setting the cut
off at 50 fluorescence units (FU). The resulting sizing table was
exported and the data was prepared for uploading to the T-RFLP
analysis expedited software (T-Rex), which included creating a
‘genemapper’ and label file [15,16]. For the genemapper file, a
different fluorophor was assigned to the values derived from
Hpy166II (Green) as compared to Tsp509I (Blue), which allowed
the combined analysis of both enzymes for each sample at the
same time. For processing the data with T-Rex, no additional filter
for noisy peaks was set but clustering thresholds of 2.0 were used to
align the TFs.
Cloning and Sequencing
Purified PCR products were cloned into the pGEM-T Easy
Vector (Promega) as per manufacturer’s instructions. 20 colonies
per ligation were picked at random. Plasmid DNA was purified
using the Qiagen Plasmid Miniprep Kit and sequenced as
described [6]. This protocol still results in longer reads as
compared to pyrosequencing protocols and therefore allows
precise assignment of bacterial taxa. Resulting sequences were
submitted to GenBank (accession numbers JQ745789–JQ746034).
Statistical Analysis
For comparing TF mean richness (mean number of TFs within
all samples) between different environments, we performed
unpaired t-test using Statview software defining significance if
the two tailed p-value was,0.05. For the additive main effects and
multiplicative interaction model (AMMI) of T-Rex, data included
was based on TF presence, but not height or peak area [15,16].
Table 2. DNA sequencing and subsequent taxa assignments of the most prevalent Tsp509I terminal fragments (TFs) derived from
15 samples with different T-RFLP patterns.
In silico TF in bp In vitro TF in bp Taxa assignation Number of samples with TF (%) Number of DNA Sequences
671 665 Streptococcus spp. 1* 105 (68.6) 84
541 535 Moraxella spp. 1 48 (31.4) 7
524 518 Corynebacterium spp. 45 (29.4) 32
207 204 Streptococcus spp. 2* 32 (20.9) 14
469 464 Haemophilus influenzae 21 (13.7) 3
358 352 Neisseria spp. 13 (8.5) 8
153 & 156 148 Moraxella spp. 2 & Sphingobacterium spp. 9 (5.9) 3 & 14**
558 550 Staphylococcus spp. 7 (4.6) 8
501 496 Prevotella spp. 5 (3.3) 5
195 190 Streptococcus pyogenes 5 (3.3) 4
561 552 Gemella spp. 4 (2.6) 1
591 583 Granulicatella spp. 4 (2.6) 3
551 544 Stenotrophomonas maltophilia 3 (2.0 8
190 185 Chrysebacterium spp. 1 3 (2.0) 6
702 697 Chrysebacterium spp. 2 2 (1.3) 6
204 199 Microbacterium spp. 1 2 (1.3) 14
374 371 Fusobacterium spp. 2 (1.3) 1
169 167 Turicella spp. 1 (0.7) 6
549 540 Klebsiella spp. 1 (0.7) 1
645 640 Propionibacterium spp. 1 (0.7) 3
209 206 Porphyromonas spp. 1 (0.7) 1
529 524 Microbacterium spp. 2 1 (0.7) 1
TOTAL 153 (100) 233
*Streptococcus pneumoniae and pseudopneumoniae are included in Streptococcus spp. 1 while other members of the Mitis group are included in Streptococcus spp. 2.
Using the second restriction enzyme (Hpy166II) Streptococcus spp. 1 can be further divided into S. pneumoniae and S. pseudopneumoniae (see text).
**Two different bacterial assignments were retrieved for TF with 148 base pairs (bp).
doi:10.1371/journal.pone.0052241.t002
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AMMI plot was derived by R as suggested by T-Rex. The function
‘‘mantel’’ in R was used to find the Mantel statistic as a matrix
correlation between two dissimilarity matrices derived by the two
enzymes.
Results
In silico Design of Terminal Restriction Fragment Length
Polymorphism (T-RFLP) for the Nasopharynx
We first downloaded the complete 16S rRNA sequences of 38
bacterial strains characteristic for the nasopharynx based on
previous studies from the ncbi webpage (www.ncbi.nlm.nih.gov),
which we sheared in 4 different primer pair groups ranging
from 8F-907, 8F-1391, 341–907 and 341–1391 (E. coli
numbering). All commercially available restriction enzymes
(n = 189) were then tested for optimal discrimination of these
16S rRNA gene sequences. The groups 8F-907 and 8F-1391
were found to be superior and primers for 8F-907 were
subsequently designed. We then manually inspected the top 10
restriction enzymes for the additional ability to discriminate
between S. pneumoniae and other members of the Mitis group
streptococci but also within Haemophilus spp. and Staphylococcus
spp. (Table S1). We identified 2 enzymes (Tsp509I and
Hpy166II), fulfilling these criteria which we subsequently tested
in the laboratory.
In vitro Evaluation of the Restriction Enzymes Tsp509I and
Hpy166II
For a proof of principle, we subsequently verified in vitro 14 of
the 38 species that had been examined by in silico analysis. The
strains represented the following taxa: Corynebacteriaceae, Strepococca-
ceae, Staphylococcaceae, Haemophilus influenzae, Moraxella catarrhalis and
Klebsiella pneumoniae (Table 1). Results showed that TF sizes
calculated in silico differed consistently about 1% of the predicted
in vitro values (Table 1). The detection limit of the in vitro T-RFLP
experiment was about 30 genome copies ml21 with the exception
of H. influenzae and M. catarrhalis (100 copies ml21; data not shown).
A differentiation between S. pneumoniae and other members of
Mitis group streptococci could also be achieved (Table 1).
However, the restriction enzyme TSP509I alone could not
differentiate between S. pneumoniae and S. pseudopneumoniae. This
could only be achieved when results of TSP509I and Hpy166I were
analyzed in combination (Table 1).
Overall TF Richness and Taxonomic Assignment
16S rRNA T-RFLP was performed for 153 nasopharyngeal
samples from infants with otitis media using the two different
restriction enzymes. Overall only 5 (using Tsp509I) and 6
(Hpy166II) TFs achieved a prevalence of more than 10%
(Figure 1). Overall, the mean TF richness was 2.3 TFs (61.5)
(Tsp509I) and 3.5 TFs (62.0) (Hpy166II) for the 153 samples
analyzed and we received sample heterogeneity values of 17.0
Figure 2. Mantel test comparing the distance matrices of Tsp509I and Hpy166II. The analysis includes the 2 different distance matrices
derived of the T-RFLP data sets from 153 infants with acute otitis media. Illustrated is the frequency distribution of correlation coefficients generated
from 10,000 permutations, and the location of the observed value. The correlation of the pair wise distance matrices between the two restriction
enzymes is highly significant (r=0.65, P,0.001) and therefore illustrates a comparable performance.
doi:10.1371/journal.pone.0052241.g002
16S rRNA T-RFLP for the Nasopharynx
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e52241
(Tsp509I) and 13.2 (Hpy166II). We then chose 15 nasopharyngeal
samples covering all TFs with a prevalence .6% for subsequent
cloning and sequencing for taxa assignment. A total of 245
sequences of approximately 900 bp were received of which 232
could be assigned to a TF (Table 2). All TFs with a prevalence
.6% could be identified with DNA sequencing allowing a
sufficient description of bacterial community changes for the most
important bacterial taxa. Streptococcus spp., H. influenzae, Moraxella
spp. Corynebacterium spp. and Staphylococcus spp. were identified most
frequently (Table 2).
Correlation of Distance Matrices and Comparison with
454 Pyrosequencing and Pneumococcal Culture Data
The performance of the 2 restriction enzymes was evaluated by
creating pairwise distance matrices for all 153 samples and a
subsequent mantel test. This revealed a high correlation between
the two restriction enzymes (r = 0.65; Figure 2).
Comparing T-RFLP with recently published 454 pyrosequenc-
ing data revealed that Moraxellaceae, Streptococcaceae, Pasteurellaceae,
Staphylococcaceae and Corynebacteriaceae were the most frequent
bacterial families within the 153 samples with both methods
[10]. However, the absolute frequencies of Moraxellaceae and
Pasteurellaceae, were increased in the 454 compared to the T-RFLP
data set. This therefore means that the two methods showed
different absolute sensitivity values.
Pneumococcal culture detected S. pneumoniae in 80 samples
(52.3%). In comparison, 79 S. pneumoniae could be identified with
the T-RFLP method if results of TSP509I and Hpy166I were
analysed in combination (100% specificity and 98.8% sensitivity).
Demographic Factors Influencing the Mean Richness of
TFs and Whole Microbial Community Comparison
Measuring mean richness differences within sex, day care and
recent treatment with antibiotics did not reveal significant
outcomes (Table 3). In contrast, PCV-7 vaccination status, year
of sampling (prevaccine versus vaccine era) and age were identified
as factors significantly influencing TF mean richness. Using an
Additive Main Effects and Multiplicative Interaction Model
(AMMI) revealed higher percentages of signal compared to noise
interaction effects for prior antibiotic exposure (4.8 versus 1.0),
samples from the vaccine era (3.4 versus 0.8) and age (1.5 versus
1.2). AMMI findings therefore conclude that antibiotic exposure
and sampling in vaccine era mostly influenced the nasopharyngeal
microbiota which was also illustrated in a Principal Component
Analysis (PCA) plot (Figure 3).
These findings are in line with the pyrosequencing data
published recently and therefore show the validity of the proposed
Figure 3. Additive Main Effects and Multiplicative Interaction Model (AMMI) analysis of bacterial T-RFLP data sets. Using the software
T-Rex (T-RFLP analysis Expedited) [15], T-RFLP profiles were first analyzed individually and then grouped according to antibiotic exposure, vaccine
season and vaccine status in the software R. The quadrates illustrate the centroids of the individual data points and represent the following: A)
prevaccine era, not vaccinated, no antibiotic exposure. B) vaccine era, not vaccinated, no antibiotic exposure. C) vaccine era, vaccinated, no antibiotic
exposure. A_ab) prevaccine era, not vaccinated, antibiotic exposure. B_ab) vaccine era, not vaccinated, antibiotic exposure. C_ab) vaccine era,
vaccinated, antibiotic exposure. According to AMMI, antibiotic exposure (grey versus black) and vaccine season (A and A_ab versus others)
significantly influences the microbiota (see text and Table 3).
doi:10.1371/journal.pone.0052241.g003
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T-RFLP method [10]. With sequencing, antibiotic exposure
(p,0.005), and seasonality (prevaccine versus vaccine era)
(p,0.05) were also shown to significantly influence the microbiota
in the nasopharynx of children with AOM despite using different
analysis tools. However, sequencing additionally revealed that
PCV-7 vaccination status also has an influence (p,0.05).
Demographic Factors Influencing Prevalence of Bacterial
Community Members within Study Subjects
Subsequently, differences in the prevalence of the most frequent
bacterial genera were calculated among the groups described
above. Children with prior antibiotic exposure had a significantly
lower prevalence of Streptococcus spp. TFs (p=0.03) but a higher
prevalence of Haemophilus influenzae. (Table 4) (p=0.03). Corynebac-
terium spp. prevalence was lower for both, PCV-7 vaccination
(p=0.02) and samples originating from the vaccine era (p=0.004).
Sequencing revealed an higher prevalence of Pasteurellaceae and a
lower prevalence of Streptococcaceae for children with antibiotic
exposure [10]. This was confirmative as well as the lower
prevalence of Corynebacteriaceae with PCV-7 status and seasonality.
However, sequencing additionally found many more commensals
being influenced by antibiotic treatment and PCV-7 but their
prevalence was small and fell beyond detection limit of the 16S
gene T-RFLP. Their importance as persistent or transient
colonizers has to be revealed in the future.
Discussion
In this study, a novel 16S rRNA T-RFLP method was developed
using 2 restriction enzymes (TSP509I and Hpy166I) able to
discriminate colonizers of the nasopharynx most efficiently.
Despite known high 16S rRNA gene sequence homology for
members of the Mitis group, the enzymes were also able to
discriminate among streptococcal species. So far, differentiation of
S. pneumoniae from other Mitis group members was hampered by
the close genetic homogeneity and horizontal gene transfer [17].
Analyzing 634 strains, Scholz et al. recently demonstrated a
mutation in the 16S rRNA gene which reliably discriminated
pneumococci from other members of the Mitis group [18]. This
SNP is the corresponding cutting site for the two restriction
enzymes TSP509I and Hpy166I and therefore enables this specific
discrimination.
Within our study, we used the T-REX (T-RFLP analysis
EXpedited) for data analysis [15]. This software has originally
been designed for the analysis of T-RFLP data from soil
communities but its applicability for studies of the human
microbiome has recently been demonstrated [19]. This software
offers two approaches for an automated alignment (binning) of
peaks. We used the option which models the approach taken by
the software program T-Align [20] and set the clustering threshold
at 2.0. Setting an appropriate value for the clustering threshold is
crucial for the evaluation of the TF richness. Setting it too low or
too high may lead to an over- and underestimation of TF richness,
respectively. This is a drawback of the methodology but newly
developed, high throughput sequencing technologies face the same
challenge as analyzing sequencing data also involves defining of
Operational Taxonomic Units (OTU) based on an incidental cut
off (most often 97% sequence identity) [21].
Another important factor for the optimal detection sensitivity is
the choice of primers for the experiment. A recent study using the
same forward but a different reverse primer revealed that T-RFLP
was able to detect S. aureus when there were more than 30 genome
Table 3. Terminal fragment (TF) richness and interaction effects resulting from two restriction enzymes (Tsp509I and Hpy166II).
TF richness Tsp509I TF richness Hpy166II Interaction effects (%)*
n Mean SD p Mean SD p Signal Noise
Sex
female 74 2.3 1.6 0.68 3.45 2.03 0.76 -0.1 1.4
male 79 2.2 1.4 3.48 2.10
Day care**
yes 54 2.3 1.4 0.69 3.52 1.96 0.78 0.4 1.3
no 89 2.2 1.5 3.38 2.08
Age
0 61 2.6 1.7 0.04 4.08 2.25 ,0.01 1.5 1.2
1 92 2.1 1.3 3.05 1.83
Antibiotic treatment
yes 39 2.4 1.8 0.48 3.51 2.45 0.79 4.8 1.0
no 114 2.2 1.4 3.45 1.92
Seven valent pneumococcal polysaccharide vaccine (PCV-7)
yes 87 2.0 1.2 0.01 3.07 1.74 ,0.01 0.8 1.3
no 66 2.6 1.7 3.98 2.33
Season
prevaccine era 31 3.1 2.1 ,0.01 4.65 2.47 ,0.01 3.4 0.8
vaccine era 122 2.0 1.2 3.2 1.8
*Received by Additive Main Effects and Multiplicative Interaction Model (AMMI). Variation due to interaction effects can have a considerable range and reflect how
similar or dissimilar the microbial communities are [15]. Therefore the more positive the difference between signal and noise, the more likely the parameters are
influencing the communities [15,16].
**No data concerning day care for 10 children.
doi:10.1371/journal.pone.0052241.t003
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copies ml21 in 50 ml DNA extract from a nasal swab [22]. While
we discovered a comparable detection limit for Streptococcus spp.
and Corynebacterium spp., this was not the case for Haemophilus
influenzae and Moraxella spp., probably due to a SNP present in the
conserved region of the forward primer and therefore suboptimal
PCR efficiency. Indeed, when comparing T-RFLP with 454
pyrosequencing data [10], Haemophilus influenzae and Moraxella spp.
were less but Corynebacterium spp. and Streptococcus spp. more
prevalent in the T-RFLP data set compared to sequencing.
However, the relative changes among the groups were reproduc-
ible with the prevalence of Haemophilus influenzae being higher and
Corynebacterium spp. being lower in the children exposed to
antibiotic treatment and PCV-7, respectively. It is known that
no primer pair is optimal for all members of a microbial
community and the use of ambiguous primers, though there is a
more optimal coverage in silico, does not necessarily improve PCR
efficiency in vitro [23]. Additional reasons why received results may
not always reflect the very correct bacterial composition of the
clinical samples are for example the different copy numbers of the
16S rRNA gene within different bacterial members.
In our study, overall TF richness was low while sample
heterogeneity was high compared to a recent study analyzing
the oral communities [19]. Although it is known that the bacterial
diversity in the nasopharynx is lower than in the oropharynx, the
TF richness results may still seem surprisingly low. However, all
the infants included in this study had acute otitis media which may
have additionally reduced diversity compared to healthy children.
In fact, most of these infants may have presented with a bacterial
infection which has previously shown to reduce overall diversity
[24].
In order to show the validity of the proposed T-RFLP method
we additionally investigated if the same factors were influencing
the microbiota of the 153 samples as received by recently
published 454 pyrosequencing data [10]. We hypothesized that
although the detection limit and amplification protocols of the two
methods are slightly different the outcome had to be same in order
to show the robustness of the T-RFLP method. The two main
factors influencing the composition of the nasopharyngeal flora
were prior exposure to antibiotics and PCV-7 vaccination.
However, 16s rRNA gene T-RFLP only identified seasonality
(prevaccine versus vaccine era) and not PCV-7 status as a driving
factor for the composition of the microbiota while 454 data
showed an influence of both. Age, day care and sex did not show
an influence on the microbiota which was in accordance with our
previous study [10].
Finally, we investigated if PCV-7 vaccination status and
seasonality and antibiotic treatment were affecting frequencies of
individual bacterial members of the nasopharynx in concordance
tot 454 pyrosequencing results.
As expected, Haemophilus influenzae showed higher and commen-
sal streptococci a lower prevalence in infants with antibiotic
exposure. In addition prevalence of Corynebacterium spp. was lower
in infants vaccinated with PCV-7 which was also in accordance to
previously described results [10].
In conclusion, this study describes the development and
validation of a 16S rRNA T-RFLP method to characterize the
nasopharyngeal microbiota. It is not as sensitive for Haemophilus
influenzae and Moraxella spp. as a recently published 454 pyrose-
quencing approach, but, in contrast, is able to discriminate
bacterial species within the Mitis group of streptococci as the
Table 4. Prevalence of the most frequent bacterial taxa.
Total
Haemophilus
influenzae**
Corynebacterium
spp.**
Moraxella
spp.**
Streptococcus
spp. (1)**
Streptococcus
spp. (2)**
n n (%) p n (%) p n (%) p n (%) p n (%) p
Sex
female 74 8 (11) 0.35 22 (30) 1 26 (35) 0.38 51 (69) 1 15 (20) 1
male 79 13 (16) 23 (29) 22 (28) 54 (68) 17 (22)
Day care*
yes 54 7 (13) 1 14 (26) 0.2 19 (35) 0.71 41 (76) 0.14 11 (20) 1
No 89 13 (15) 31 (35) 28 (31) 56 (63) 18 (20)
Age
0 years 61 9 (15) 0.81 22 (36) 0.15 22 (36) 0.37 37 (61) 0.11 16 (26) 0.22
1 years 92 12 (13) 23 (25) 26 (28) 68 (74) 16 (17)
Antibiotic treatment
Yes 39 10 (26) 0.03 7 (18) 0.1 10 (26) 0.43 21 (54) 0.03 11 (28) 0.25
No 114 12 (11) 38 (33) 38 (33) 84 (74) 21 (18)
Seven valent pneumococcal polysaccharide vaccine (PCV-7)
yes 87 13 (15) 0.64 19 (22) 0.02 28 (32) 0.86 57 (66) 0.38 17 (20) 0.69
no 66 8 (12) 26 (39) 20 (30) 48 (73) 15 (23)
Season
prevaccine era 31 5 (16) 0.77 16 (52) 0.004 10 (32) 1 23 (74) 0.52 9 (29) 0.22
vaccine era 122 16 (13) 29 (24) 38 (31) 82 (67) 23 (19)
*No data concerning day care for 10 children.
**Data based on Tsp509I received TFs of 464 bp (Haemophilus influenzae), 518 bp (Corynebacterium spp.) 535 bp (Moraxella spp.), 665 bp (Streptococcus spp. 1) and
204 bp (Streptococcus spp. 2). Streptococcus pneumoniae and pseudopneumoniae are included in Streptococcus spp. 1 while other members of the Mitis group are
included in Streptococcus spp. 2 (see Table 2).
doi:10.1371/journal.pone.0052241.t004
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designed primer pair spans the regions with the relevant SNP.
Both approaches do therefore not show the ‘optimal’ resolution of
the microbial communities but reach the same conclusion that the
introduction of PCV-7 and prior antibiotic exposure had effects on
the composition of the flora. If used complimentary and validated
carefully, we therefore suggest that in ‘omics’ era there is still a
place for well-established methods like T-RFLP as they are cost
effective, rapidly performed and interpreted.
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